R. Ziegler

No ORCID on file · 3 papers in corpus · active 1989-2009

Study types

  • article 2
  • other 1

Condition tags

  • endometriosis 3
article 2009
Add-back medrogestone does not prevent bone loss in premenopausal women treated with goserelin
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association ·doi:10.1055/s-0029-1212129

To investigate the effect of medrogestone on bone mineral density (BMD) and bone turnover under conditions of estrogen withdrawal, premenopausal women with endometriosis were treated with goserelin (Zoladex), combined with either placebo (g…

other 1990
Bone mass reduction after estrogen deprivation by long-acting gonadotropin-releasing hormone agonists and its relation to pretreatment serum concentrations of 1,25-dihydroxyvitamin D3
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem-70-4-1055

Estrogen deficiency results in bone mass reduction of largely varying extent in postmenopausal females, indicating that additional mechanisms influence the response of bone. They are by no ways identified in either the animal experiment or …

article 1989
Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma
Human Reproduction ·doi:10.1093/oxfordjournals.humrep.a136912

Oestrogen deficiency at the menopause is associated with changes in calcium and bone metabolism. Hypo-oestrogenism induced by the use of GnRH-agonists is clinically useful in the treatment of oestrogen-dependent diseases. This study was don…